Your browser doesn't support javascript.
loading
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells.
Saraon, Punit; Snider, Jamie; Schormann, Wiebke; Rai, Ankit; Radulovich, Nikolina; Sánchez-Osuna, Maria; Coulombe-Huntington, Jasmin; Huard, Caroline; Mohammed, Mohammed; Lima-Fernandes, Evelyne; Thériault, Brigitte; Halabelian, Levon; Chan, Manuel; Joshi, Dhananjay; Drecun, Luka; Yao, Zhong; Pathmanathan, Shivanthy; Wong, Victoria; Lyakisheva, Anna; Aboualizadeh, Farzaneh; Niu, Li; Li, Fengling; Kiyota, Taira; Subramanian, Ratheesh; Joseph, Babu; Aman, Ahmed; Prakesch, Michael; Isaac, Methvin; Mamai, Ahmed; Poda, Gennady; Vedadi, Masoud; Marcellus, Richard; Uehling, David; Leighl, Natasha; Sacher, Adrian; Samarzija, Miroslav; Jakopovic, Marko; Arrowsmith, Cheryl; Tyers, Mike; Tsao, Ming-Sound; Andrews, David; Al-Awar, Rima; Stagljar, Igor.
Afiliación
  • Saraon P; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada. Electronic address: punit.saraon@oicr.on.ca.
  • Snider J; Donnelly Centre, University of Toronto, Ontario, Canada.
  • Schormann W; Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Rai A; Cell Biology, Department of Biology, Faculty of Science, Utrecht University, 3548CH Utrecht, the Netherlands.
  • Radulovich N; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Sánchez-Osuna M; Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Downtown Station, Montreal, QC H3C 3J7, Canada.
  • Coulombe-Huntington J; Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Downtown Station, Montreal, QC H3C 3J7, Canada.
  • Huard C; Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Downtown Station, Montreal, QC H3C 3J7, Canada.
  • Mohammed M; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Lima-Fernandes E; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Thériault B; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Halabelian L; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Chan M; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Joshi D; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Drecun L; Donnelly Centre, University of Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Ontario, Canada.
  • Yao Z; Donnelly Centre, University of Toronto, Ontario, Canada.
  • Pathmanathan S; Donnelly Centre, University of Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Ontario, Canada.
  • Wong V; Donnelly Centre, University of Toronto, Ontario, Canada.
  • Lyakisheva A; Donnelly Centre, University of Toronto, Ontario, Canada.
  • Aboualizadeh F; Donnelly Centre, University of Toronto, Ontario, Canada.
  • Niu L; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Li F; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Kiyota T; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Subramanian R; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Joseph B; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Aman A; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Prakesch M; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Isaac M; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Mamai A; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Poda G; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada; University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada.
  • Vedadi M; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Ontario, Canada.
  • Marcellus R; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Uehling D; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Leighl N; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Sacher A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Samarzija M; Department for Lung Diseases Jordanovac, Clinical Hospital Centre Zagreb, University of Zagreb, Zagreb, Croatia.
  • Jakopovic M; Department for Lung Diseases Jordanovac, Clinical Hospital Centre Zagreb, University of Zagreb, Zagreb, Croatia.
  • Arrowsmith C; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Tyers M; Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Downtown Station, Montreal, QC H3C 3J7, Canada.
  • Tsao MS; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Andrews D; Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Al-Awar R; Drug Discovery Program, Ontario Institute for Cancer Research, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Ontario, Canada. Electronic address: rima.alawar@oicr.on.ca.
  • Stagljar I; Donnelly Centre, University of Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Ontario, Canada; Department of Biochemistry, University of Toronto, Ontario, Canada; Mediterranean Institute for Life Sciences, Split, Croatia; School of Medicine, University of Split, S
J Mol Biol ; 433(23): 167294, 2021 11 19.
Article en En | MEDLINE | ID: mdl-34662547
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Tirosina Quinasas Receptoras / Proteína Coatómero / Descubrimiento de Drogas / Estrés del Retículo Endoplásmico Tipo de estudio: Prognostic_studies Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Tirosina Quinasas Receptoras / Proteína Coatómero / Descubrimiento de Drogas / Estrés del Retículo Endoplásmico Tipo de estudio: Prognostic_studies Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article